Protease-activated Receptor-3 (PAR3) Regulates PAR1 Signaling by Receptor Dimerization

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2007 Mar 23

PMID 17376866

Citations 93

Authors

Joseph N McLaughlin

Myla M Patterson

Asrar B Malik

Affiliations

Soon will be listed here.

Abstract

Thrombin activates endothelial cell signaling by cleaving the protease-activated receptor-1 (PAR1). However, the function of the apparently nonsignaling receptor PAR3 also expressed in endothelial cells is unknown. We demonstrate here the crucial role of PAR3 in potentiating the responsiveness of PAR1 to thrombin. We tested the hypothesis that PAR1/PAR3 heterodimerization and its effect in modifying G protein selectivity was responsible for PAR3 regulation of PAR1 sensitivity. Using bioluminescent resonance energy transfer-2, we showed that PAR1 had comparable dimerization affinity for PAR3 as for itself. We observed increased Galpha(13) coupling between the PAR1/3 heterodimer compared with the PAR1/1 homodimer. Moreover, knockdown of PAR3 moderated the PAR1-activated increase in endothelial permeability. These results demonstrate a role of PAR3 in allosterically regulating PAR1 signaling governing increased endothelial permeability. Because PAR3 is a critical determinant of PAR1 function, targeting of PAR3 may mitigate the effects of PAR1 in activating endothelial responses such as vascular inflammation.

Citing Articles

An orthosteric/allosteric bivalent peptide agonist comprising covalently linked protease-activated receptor-derived peptides mimics in vitro and in vivo activities of activated protein C.

Healy L, Fernandez J, Aiolfi R, Mosnier L, Griffin J J Thromb Haemost. 2024; 22(7):2039-2051.

PMID: 38670314 PMC: 11610403. DOI: 10.1016/j.jtha.2024.04.007.

Diversification of PAR signaling through receptor crosstalk.

Lee-Rivera I, Lopez E, Lopez-Colome A Cell Mol Biol Lett. 2022; 27(1):77.

PMID: 36088291 PMC: 9463773. DOI: 10.1186/s11658-022-00382-0.

Protease-activated receptors in health and disease.

Peach C, Edgington-Mitchell L, Bunnett N, Schmidt B Physiol Rev. 2022; 103(1):717-785.

PMID: 35901239 PMC: 9662810. DOI: 10.1152/physrev.00044.2021.

Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage.

Zolotoff C, Puech C, Roche F, Perek N Sci Rep. 2022; 12(1):12305.

PMID: 35853902 PMC: 9296553. DOI: 10.1038/s41598-022-15592-x.

Gα and Gα: Versatility in Physiology and Pathology.

Guo P, Tai Y, Wang M, Sun H, Zhang L, Wei W Front Cell Dev Biol. 2022; 10:809425.

PMID: 35237598 PMC: 8883321. DOI: 10.3389/fcell.2022.809425.

References

Malik A, Fenton 2nd J . Thrombin-mediated increase in vascular endothelial permeability. Semin Thromb Hemost. 1992; 18(2):193-9. DOI: 10.1055/s-2007-1002425. View

Vu T, Hung D, Wheaton V, Coughlin S . Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991; 64(6):1057-68. DOI: 10.1016/0092-8674(91)90261-v. View

Tiruppathi C, Malik A, Del Vecchio P, Keese C, Giaever I . Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc Natl Acad Sci U S A. 1992; 89(17):7919-23. PMC: 49826. DOI: 10.1073/pnas.89.17.7919. View

Hung D, Wong Y, Vu T, Coughlin S . The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem. 1992; 267(29):20831-4. View

Chen J, Ishii M, Wang L, Ishii K, Coughlin S . Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem. 1994; 269(23):16041-5. View

Rabiet M, Plantier J, Dejana E . Thrombin-induced endothelial cell dysfunction. Br Med Bull. 1994; 50(4):936-45. DOI: 10.1093/oxfordjournals.bmb.a072935. View

Barr A, Brass L, Manning D . Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor.G protein coupling. J Biol Chem. 1997; 272(4):2223-9. DOI: 10.1074/jbc.272.4.2223. View

Ishihara H, Connolly A, Zeng D, Kahn M, Zheng Y, Timmons C . Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997; 386(6624):502-6. DOI: 10.1038/386502a0. View

Hart M, Jiang X, Kozasa T, ROSCOE W, Singer W, GILMAN A . Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science. 1998; 280(5372):2112-4. DOI: 10.1126/science.280.5372.2112. View

10.

Damiano B, Cheung W, Santulli R, Ngo K, Ye R, Darrow A . Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther. 1999; 288(2):671-8. View

11.

Kaufmann R, Schulze B, Krause G, Mayr L, Settmacher U, Henklein P . Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1. Regul Pept. 2004; 125(1-3):61-6. DOI: 10.1016/j.regpep.2004.07.032. View

12.

Pfleger K, Eidne K . Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells. Biochem J. 2004; 385(Pt 3):625-37. PMC: 1134737. DOI: 10.1042/BJ20041361. View

13.

Vesey D, Cheung C, Kruger W, Poronnik P, Gobe G, Johnson D . Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. Kidney Int. 2005; 67(4):1315-29. DOI: 10.1111/j.1523-1755.2005.00209.x. View

14.

Gales C, Rebois R, Hogue M, Trieu P, Breit A, Hebert T . Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods. 2005; 2(3):177-84. DOI: 10.1038/nmeth743. View

15.

McLaughlin J, Mazzoni M, Cleator J, Earls L, Perdigoto A, Brooks J . Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells. J Biol Chem. 2005; 280(23):22172-80. DOI: 10.1074/jbc.M500721200. View

16.

McLaughlin J, Shen L, Holinstat M, Brooks J, DiBenedetto E, Hamm H . Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem. 2005; 280(26):25048-59. DOI: 10.1074/jbc.M414090200. View

17.

Hein P, Frank M, Hoffmann C, Lohse M, Bunemann M . Dynamics of receptor/G protein coupling in living cells. EMBO J. 2005; 24(23):4106-14. PMC: 1356310. DOI: 10.1038/sj.emboj.7600870. View

18.

Leger A, Jacques S, Badar J, Kaneider N, Derian C, Andrade-Gordon P . Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation. 2006; 113(9):1244-54. DOI: 10.1161/CIRCULATIONAHA.105.587758. View

19.

Jastrzebska B, Fotiadis D, Jang G, Stenkamp R, Engel A, Palczewski K . Functional and structural characterization of rhodopsin oligomers. J Biol Chem. 2006; 281(17):11917-22. PMC: 1618955. DOI: 10.1074/jbc.M600422200. View

20.

Cepkova M, Matthay M . Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med. 2006; 21(3):119-43. PMC: 2765330. DOI: 10.1177/0885066606287045. View